Clinical Trial Update: Study of Two Intrathecal Doses of Autologous Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

This entry describes a Phase 1/2 clinical trial evaluating two intrathecal doses of autologous mesenchymal stem cells in individuals with amyotrophic lateral sc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Autologous mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: AMYOTROPHIC LATERAL SCLEROSIS | Phase 1, Phase 2 | Status: UNKNOWN